Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: AgFinder who wrote (2843)	5/19/1999 12:44:00 PM
From: Biomaven	Read Replies (5) of 10280

A ultra quick report of the shareholder meeting. I'll post some more detail later. 1. About 75 people, up from last year. Lots of questions - meeting lasted over 2 hours. 2. All resolutions passed, although option plan must have been close - some institutions won't support these unless they have certain provisions, and maybe that was what happened here. 3. Generally a very constructive and informative meeting. When you focus on single issues (like nora) you tend to forget the breadth of their development pipeline. 4. Didn't hear a single piece of new bad news. 5. Xopenex: "incredibly encouraged" by reports from the field; too early for sales data. 6. Most excited about Meridia ICE (for indications other than obesity). Knoll (who owns Meridia) was described as "very reasonable." Could do this one on their own, as patent is expiring and their ICE is not effected by extension. 7. Basis for FTC investigation of Prozac deal is a mystery to them. Timing is unknown. 8. All-in-all a very encouraging meeting. More details later. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next